Essential drug availability, pricing policy to be revisited

Staff Reporter

Islamabad—Ministry of National Health Services, Regulations Coordination and Pharmaceutical Manufacturers have agreed in principle to revisit the Essential Drug Availability and Pricing Policy. The existing drug policy was discussed threadbare and there emerged consensus on amendments required in the policy for meeting the objectives of availability of efficacious, affordable and quality essential drugs.
A meeting of the subcommittees of the Convenors constituted by the Wafaqi Mohtasib was held under the Chairmanship of Brig. (Retd) Dr. Muzammil Hassan Najmi, Prof. Fauji Foundation University Medical College, Islamabad and Dr. Inam ul Haq, Former Drugs Controller and Chairman Quality Control Authority and Dean and Director, Riphah Institute of Pharmaceutical Sciences, to study Measures for Availability of Essential Drugs at the Public Sector Hospitals & Clinics, Drugs Pricing and Quality Control Mechanism for Essential Drugs.
The Honourable Wafaqi Mohtasib Mr. M. Salman Faruqui was apprised by the Convenors of the subcommittee on the progress made to ensure the availability of Essential Drugs at affordable prices. The Wafaqi Mohtasib appreciated the efforts of the Government and the manufacturers which are being made to resolve the issue of availability of Essential Drugs at affordable price. He stated that Wafaqi Mohtasib Secretariat had taken cognizance of the non-availability of Essential Drugs in the country and had constituted a committee comprising eminent doctors, pharmacists, drug manufacturers and other stake holders. He emphasized the need for speedy finalization of the report as it affects the health of the people.
Mr. Jaweed Akhter, Senior Advisor, Wafaqi Mohtasib Secretariat and Secretary of the Committee on Essential Drugs gave detailed briefings to the members on the committee’s deliberations and other consultative meetings held with the stakeholders in this connection.

Share this post

    scroll to top